These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35315858)

  • 21. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
    Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
    Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEGylation of phytantriol-based lyotropic liquid crystalline particles--the effect of lipid composition, PEG chain length, and temperature on the internal nanostructure.
    Nilsson C; Østergaard J; Larsen SW; Larsen C; Urtti A; Yaghmur A
    Langmuir; 2014 Jun; 30(22):6398-407. PubMed ID: 24833115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Size-Dependent Encapsulation and Release of dsDNA from Cationic Lyotropic Liquid Crystalline Cubic Phases.
    Sarkar S; Tran N; Soni SK; Conn CE; Drummond CJ
    ACS Biomater Sci Eng; 2020 Aug; 6(8):4401-4413. PubMed ID: 33455184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple-by-design approach for production of stabilizer-free cubosomes from phosphatidylglycerol and docosahexaenoic acid monoacylglycerol.
    Kalaycioglu GD; Bor G; Yaghmur A
    J Colloid Interface Sci; 2024 Dec; 675():825-835. PubMed ID: 39002233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cubosomes: an overview.
    Garg G; Saraf S; Saraf S
    Biol Pharm Bull; 2007 Feb; 30(2):350-3. PubMed ID: 17268078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell interactions with lipid nanoparticles possessing different internal nanostructures: Liposomes, bicontinuous cubosomes, hexosomes, and discontinuous micellar cubosomes.
    Yap SL; Yu H; Li S; Drummond CJ; Conn CE; Tran N
    J Colloid Interface Sci; 2024 Feb; 656():409-423. PubMed ID: 38000253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Versatile Nanocarrier-Cubosomes, Characterization, and Applications.
    Oliveira C; Ferreira CJO; Sousa M; Paris JL; Gaspar R; Silva BFB; Teixeira JA; Ferreira-Santos P; Botelho CM
    Nanomaterials (Basel); 2022 Jun; 12(13):. PubMed ID: 35808060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
    Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
    Micron; 2007; 38(5):478-85. PubMed ID: 17011783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cubosomes as Carriers for MRI Contrast Agents.
    Alcaraz N; Boyd BJ
    Curr Med Chem; 2017; 24(5):470-482. PubMed ID: 27538694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanostructured cubosomes as a platform for oral drug delivery.
    Liu M; Chen M; Xu P; Yang Z
    Curr Pharm Biotechnol; 2015; 16(4):313-21. PubMed ID: 25601599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications.
    Dong YD; Larson I; Barnes TJ; Prestidge CA; Allen S; Chen X; Roberts CJ; Boyd BJ
    Langmuir; 2012 Sep; 28(37):13485-95. PubMed ID: 22889049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines.
    Rizwan SB; Assmus D; Boehnke A; Hanley T; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2011 Sep; 79(1):15-22. PubMed ID: 21237267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
    Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
    J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy.
    Singh S; Sachan K; Verma S; Singh N; Singh PK
    Curr Pharm Biotechnol; 2024; 25(6):757-771. PubMed ID: 37929730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-lamellar lipid liquid crystalline structures at interfaces.
    Chang DP; Barauskas J; Dabkowska AP; Wadsäter M; Tiberg F; Nylander T
    Adv Colloid Interface Sci; 2015 Aug; 222():135-47. PubMed ID: 25435157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of particulate lipid lyotropic liquid crystalline nanocarriers using a microfluidic platform.
    Yu H; Dyett BP; Zhai J; Strachan JB; Drummond CJ; Conn CE
    J Colloid Interface Sci; 2023 Mar; 634():279-289. PubMed ID: 36542965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
    Zabara A; Mezzenga R
    J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct visualization of dispersed lipid bicontinuous cubic phases by cryo-electron tomography.
    Demurtas D; Guichard P; Martiel I; Mezzenga R; Hébert C; Sagalowicz L
    Nat Commun; 2015 Nov; 6():8915. PubMed ID: 26573367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.